Studies have shown that excess insulin circulating in the bloodstream is a major independent risk factor for cardiovascu…
Insulin
Insulin in a Capsule: The Promising Development of Oral Insulin
The creation of oral insulin has been no simple task. "People have been dreaming about oral insulin since 1922," Dr. Ki…
New Studies Show Novo Nordisk’s Combination Insulin Reduces Hypoglycemia
A study released by Novo Nordisk at the International Diabetes Federation (IDF) 21st World Diabetes Congress in Dubai ha…
Insulin Therapy Improves Blood Sugar Control in Type 2 Diabetes Patients With Few Hypoglycemic Occurrences
Data from the A1chieve® study, evaluating adverse events and effectiveness of Novo Nordisk insulins (NovoMix 30, Levemir…
Why Type 2 Diabetes Patients Resist Intensifying Insulin Treatment, Lilly to Conduct Study
Eli Lilly has announced it is conducting the first major international, prospective observational study designed to unde…
Insulin Like A String of Pearls: How Degludec Works
There was one thing about Degludec that caught my attention, and after speaking to Dr. Alan Moses of Novo Nordisk about …
Creating Glucose-Responsive Insulin: The Crowdsourcing Approach
From its isolation and first use in 1922, insulin has been called one of the few miracle drugs, saving diabetics from th…
Positive Phase 2 Results for Halozyme’s Ultra Fast Insulins
Halozyme Therapeutics, a San Diego based biopharmaceutical company, announced positive results from two Phase 2 clinical…
FDA Approves Byetta for Use with Lantus Insulin in the U.S.
The U.S. Food and Drug Administration (FDA) has approved a new use for Amylin and Eli Lilly's type 2 diabetes drug, Byet…
Novo Nordisk Requests FDA Approval for Ultra-Long-Acting Insulin Degludec
Novo Nordisk filed two new drug applications for the approval of ultra-long-acting insulin degludec and the co-formulati…
